UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

BioLife Solutions, Inc.

(Name of the Issuer)

 

Common Stock, $0.001 par value per share

(Title of Class of Securities)

 

09062W105

(CUSIP Number)

 

July 2, 2013

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate rule pursuant to which this Schedule is filed:

 

  Rule 13d-1(b)
X Rule 13d-1(c)
  Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 
 

CUSIP No.       09062W105     

 

1. Names of Reporting Persons.       John G. Baust, Ph.D.                          
  I.R.S. Identification Nos. of above persons (entities only).
   
2. Check the Appropriate Box if a Member of a Group.
  (a)  _______
  (b)  _______
   
3. SEC Use Only.
   
4. Citizenship of Place of Organization.     United States      

 

    5. Sole Voting Power.   3,694,722       
Number of Shares      
Beneficially   6. Shared Voting Power.  0                  
Owned by Each      
Reporting Person   7. Sole Dispositive Power.  3,694,722                
With:      
    8. Shared Dispositive Power.  0                         

 

9. Aggregate Amount Beneficially Owned by Each Reporting Person.  3,694,722                
   
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares.             
   
11. Percent of Class Represented by Amount in Row (9).  5.28%     
   
12. Type of Reporting Person.  IN                                                 

 

 
 

Item 1.    
  (a) Name of Issuer: BioLife Solutions, Inc.
     
  (b) Address of Issuer’s Principal Executive Office:
    3303 Monte Villa Parkway, Suite 310, Bothell, Washington 98021
     
Item 2.    
  (a) Name of Person Filing: John G. Baust, Ph.D.
     
  (b) Address of Principal Business Officer:
    3303 Monte Villa Parkway, Suite 310, Bothell, Washington 98021
     
  (c) Citizenship: United States
     
  (d) Title of Class of Securities: Common Stock, $0.001 par value per share
     
  (e) CUSIP Number: 09062W105

 

Item 3. If this statement is file pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
   
  (a) ___ Broker or dealer registered under section 15 of the Act (15 U/S.C. 78o);
       
  (b) ___ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
       
  (c) ___ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
       
  (d) ___ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
       
  (e) ___ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
  (f) ___ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) ___ A parent holding company of control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
  (h) ___ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) ___ A church plan that is excluded from the definition of an investment company under section 3( c) (14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
  (j) ___ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Item 4. Ownership
   
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned:  3,694,722            
     
  (b) Percent of Class:  5.28%                                       
     
  (c) Number of shares as to which the person has:
     
    (i) Sole power to vote or to direct the vote:   3,694,722            
       
    (ii) Shared power to vote or to direct the vote:  0
       
    (iii) Sole power to dispose or to direct the disposition of:   3,694,722            
       
    (iv) Share power to dispose or to direct the disposition of:  0

 
 

Item 5. Ownership of Five Percent or Less of a Class
   
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: o
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
   
  No person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities identified in Item 4 (c)(i)) above.
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
   
  None.
   
Item 8. Identification and Classification of Members of the Group
   
  None.
   
Item 9. Notice of Dissolution of Group
   
  None.
   
Item 10. Certification
   
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

     
    September 10, 2013
    Date
     
    /s/ John G. Baust
    Signature
     
    John G. Baust
    Name